Autor: "van der Schalk TE" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates.
Autorzy:: van der Schalk TE; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Coppens J; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.; Laboratory of Clinical Microbiology, Antwerp University Hospital , Edegem, Belgium.
Timbermont L; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Turlej-Rogacka A; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Van Heirstraeten L; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Berkell M; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Yu L; Statistical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA.
Lammens C; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Xavier BB; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.
Matheeussen V; Laboratory of Clinical Microbiology, Antwerp University Hospital , Edegem, Belgium.
Ieven M; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.; Laboratory of Clinical Microbiology, Antwerp University Hospital , Edegem, Belgium.
McCarthy M; Early-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA.
Jorens PG; Department of Intensive Care Medicine , Antwerp University Hospital , Edegem , Belgium.
Ruzin A; Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA.
Esser MT; Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA.
Kumar-Singh S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.; Molecular Pathology Group, Cell Biology and Histology, University of Antwerp, Wilrijk, Belgium.
Goossens H; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium.; Laboratory of Clinical Microbiology, Antwerp University Hospital , Edegem, Belgium.
Malhotra-Kumar S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute , University of Antwerp, Wilrijk, Belgium. .; Pokaż więcej
Źródło:: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2021 Jul 23; Vol. 10 (1), pp. 110. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Respiration, Artificial*
Bacteriological Techniques/*methods
Pseudomonas aeruginosa/*isolation & purification
Trachea/*microbiology
Belgium ; Genomics ; Humans ; Polymerase Chain Reaction ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""van der Schalk TE"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język